Fundraising Fox

Hemex Health

Portland, US · Founded 2016 · Oregon corporation · 3 known investors

Hemex Health develops and commercializes the Gazelle diagnostic platform, including point-of-care readers and tests for conditions such as sickle cell disease and hemoglobin variants. It targets clinicians, patients, and public health programs in emerging and resource-limited markets, with significant operations and manufacturing in India.

Founders & leadership

Hemex Health was founded in 2016 by Patricia White Seminario, Peter Galen, and Patti White.

PWPatricia White Seminario
Patricia White SeminarioCo-founder
PGPeter Galen
Peter GalenChief Innovation Officer, Co-Founder
PWPatti White
Patti WhiteChief Executive Officer, Co-Founder
DB
Daren BledsoeinSr. VP, Engineering & Operations
GV
Gerrit van RoekelinVP, Business Development
UG
Umut GurkaninChief Scientist, Microfluidics
NS
Nikki SiddiquiinChief Financial Officer
PK
Prashant KhadkeManaging Director, India Commercial Operations
PL
Paul LongoVP-Product Development
PA
Prakash AgarwalNamed on SEC filing
MU
Mohan UttarwarNamed on SEC filing
SM
Susan MorgenszternNamed on SEC filing

Investors · 3

Reported raises · per SEC filings

Form D private placements

$3.9M disclosed across 2 of 3 rounds · 2016–2018

$930KraisedMar 2018 · 27 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Annette MuleeDirector
  • Mohan UttarwarDirector
  • Peter GalenExecutive Officer, Director
  • Patricia White SeminarioExecutive Officer, Director
  • Prakash AgarwalDirector
  • Susan MorgenszternDirector
Offering amount
$930K
Amount sold
$930K
First sale
Jan 2018
Incorporated
Corporation, Oregon, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$27.3KofferedMar 2018 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Mohan UttarwarDirector
  • Peter GalenExecutive Officer, Director
  • Susan MorgenszternDirector
  • Patricia SeminarioExecutive Officer, Director
  • Prakash AgarwalDirector
  • Annette MuleeDirector
Offering amount
$27.3K
First sale
Jan 2018
Incorporated
Corporation, Oregon, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3MraisedDec 2017 · 46 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Prakash AgarwalDirector
  • Mohan UttarwarDirector
  • Patricia White SeminarioExecutive Officer, Director, Promoter
  • Peter GalenExecutive Officer, Director, Promoter
  • Susan MorgenszternDirector
  • Annette MuleeDirector, Promoter
Offering amount
$3M
Amount sold
$3M
First sale
Sep 2016
Incorporated
Corporation, Oregon, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Hemex Health for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 10 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2023$1M
National Institutes of Health (NIH)National Institutes of HealthPhase IISTTR2022$1.7M
National Institutes of Health (NIH)National Institutes of HealthPhase I2021$256.6K
National Institutes of Health (NIH)National Institutes of HealthPhase II2020$1.7M
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2020$225K
National Institutes of Health (NIH)National Institutes of HealthPhase II2019$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2018$225.1K
National Institutes of Health (NIH)National Institutes of HealthPhase I2018$225K
National Institutes of Health (NIH)National Institutes of HealthPhase I2018$225K
National Institutes of Health (NIH)National Institutes of HealthPhase II2017$1.5M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Hemex Health do?
Hemex Health develops and commercializes the Gazelle diagnostic platform, including point-of-care readers and tests for conditions such as sickle cell disease and hemoglobin variants. It targets clinicians, patients, and public health programs in emerging and resource-limited markets, with significant operations and manufacturing in India.
Who founded Hemex Health?
Hemex Health was founded by Patricia White Seminario, Peter Galen, Patti White in 2016.
Who are Hemex Health's investors?
Hemex Health's investors include CWRU Technology Ventures, Portland Seed Fund, Elevate Capital.
How much funding has Hemex Health raised?
Hemex Health has disclosed $3.9M raised across 2 of its 3 known rounds.
Where is Hemex Health headquartered?
Hemex Health is headquartered in Portland, US.